Page last updated: 2024-09-03

interleukin-1beta (163-171) and Acute Respiratory Distress Syndrome

interleukin-1beta (163-171) has been researched along with Acute Respiratory Distress Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abraham, I; Bime, C; Camp, SM; Carter, D; Casanova, N; Downs, CA; Garcia, JGN; Lussier, Y; Lynn, H; Mekontso-Dessap, A; Miller, EJ; Ndukum, J; Oita, RC1
Abraham, E; Cryer, HG; Donnelly, TJ; Hugli, TE; Jagels, M; Law, MM; Meade, P; Shoemaker, WC1

Other Studies

2 other study(ies) available for interleukin-1beta (163-171) and Acute Respiratory Distress Syndrome

ArticleYear
Development of a biomarker mortality risk model in acute respiratory distress syndrome.
    Critical care (London, England), 2019, 12-16, Volume: 23, Issue:1

    Topics: Adult; APACHE; Biomarkers; Cytokines; Female; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Interleukin-6; Interleukin-8; Intramolecular Oxidoreductases; Latent Class Analysis; Logistic Models; Macrophage Migration-Inhibitory Factors; Male; Middle Aged; Nicotinamide Phosphoribosyltransferase; Peptide Fragments; Respiratory Distress Syndrome; Risk Assessment; Sphingosine-1-Phosphate Receptors; Vesicular Transport Proteins

2019
Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury.
    Critical care medicine, 1994, Volume: 22, Issue:5

    Topics: Adult; Blood Gas Analysis; Complement C3a; Complement C4a; Craniocerebral Trauma; Endotoxins; Enzyme-Linked Immunosorbent Assay; Female; Hemodynamics; Humans; Injury Severity Score; Interleukin-1; Interleukin-1beta; Interleukin-6; Interleukin-8; Male; Middle Aged; Oxygen Consumption; Peptide Fragments; Predictive Value of Tests; Prognosis; Prospective Studies; Radioimmunoassay; Respiratory Distress Syndrome; Risk Factors; Survival Rate; Time Factors; Tumor Necrosis Factor-alpha

1994